Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 45% ± 14% | |
peripheral blood | 17 studies | 35% ± 11% | |
intestine | 12 studies | 38% ± 19% | |
kidney | 9 studies | 45% ± 12% | |
eye | 8 studies | 28% ± 13% | |
liver | 7 studies | 43% ± 22% | |
brain | 7 studies | 25% ± 5% | |
pancreas | 5 studies | 38% ± 12% | |
uterus | 5 studies | 55% ± 20% | |
lymph node | 5 studies | 38% ± 14% | |
placenta | 4 studies | 63% ± 28% | |
bone marrow | 4 studies | 34% ± 11% | |
adipose | 4 studies | 33% ± 21% | |
prostate | 4 studies | 41% ± 13% | |
breast | 4 studies | 43% ± 3% | |
adrenal gland | 3 studies | 29% ± 6% | |
esophagus | 3 studies | 55% ± 27% | |
thymus | 3 studies | 55% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 18861.23 | 1445 / 1445 | 100% | 245.41 | 183 / 183 |
liver | 100% | 17610.12 | 226 / 226 | 100% | 622.46 | 406 / 406 |
ovary | 100% | 10777.27 | 180 / 180 | 100% | 552.84 | 430 / 430 |
stomach | 100% | 12191.91 | 359 / 359 | 100% | 235.02 | 286 / 286 |
uterus | 100% | 12660.29 | 170 / 170 | 100% | 543.58 | 459 / 459 |
lung | 100% | 13768.42 | 577 / 578 | 100% | 366.56 | 1155 / 1155 |
kidney | 100% | 13168.62 | 89 / 89 | 100% | 319.80 | 899 / 901 |
thymus | 100% | 11673.87 | 652 / 653 | 100% | 359.19 | 604 / 605 |
skin | 100% | 13506.72 | 1807 / 1809 | 100% | 406.19 | 471 / 472 |
breast | 100% | 23534.97 | 459 / 459 | 100% | 371.71 | 1114 / 1118 |
bladder | 100% | 11458.81 | 21 / 21 | 100% | 327.34 | 502 / 504 |
prostate | 100% | 13027.71 | 244 / 245 | 100% | 521.17 | 501 / 502 |
intestine | 100% | 12163.37 | 965 / 966 | 99% | 251.85 | 524 / 527 |
adrenal gland | 100% | 16478.02 | 258 / 258 | 98% | 237.74 | 225 / 230 |
pancreas | 97% | 7064.24 | 319 / 328 | 100% | 255.69 | 178 / 178 |
brain | 95% | 8112.69 | 2507 / 2642 | 100% | 297.57 | 705 / 705 |
adipose | 100% | 27294.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 237.57 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 405.19 | 29 / 29 |
muscle | 100% | 35047.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8472.35 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 305.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 335.08 | 1 / 1 |
blood vessel | 100% | 11891.23 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 8234.79 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 18439.77 | 824 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0006979 | Biological process | response to oxidative stress |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0004602 | Molecular function | glutathione peroxidase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0051920 | Molecular function | peroxiredoxin activity |
GO_0005515 | Molecular function | protein binding |
GO_0047184 | Molecular function | 1-acylglycerophosphocholine O-acyltransferase activity |
Gene name | PRDX6 |
Protein name | Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12) |
Synonyms | AOP2 KIAA0106 |
Description | FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively . Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides . Also has phospholipase activity, can therefore either reduce the oxidized sn-2 fatty acyl group of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity) . These activities are dependent on binding to phospholipids at acidic pH and to oxidized phospholipds at cytosolic pH . Plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis . Exhibits acyl-CoA-dependent lysophospholipid acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) . Shows a clear preference for LPC as the lysophospholipid and for palmitoyl CoA as the fatty acyl substrate . . |
Accessions | P30041 ENST00000340385.6 |